发明名称 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
摘要 |
This invention is directed to quinoline/quinoxaline compounds which inhibit platelet-derived growth factor tyrosine kinase and/or Lck tyrosine kinase, to pharmaceutical compositions comprising these compounds, and to the use of these compounds for treating a patient suffering from or subject to disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or T cell activation and proliferation.
|
申请公布号 |
US6846815(B2) |
申请公布日期 |
2005.01.25 |
申请号 |
US20030357240 |
申请日期 |
2003.02.03 |
申请人 |
AVENTIS PHARMACEUTICALS INC. |
发明人 |
MYERS MICHAEL R.;SPADA ALFRED P.;PERSONS PAUL E.;MAGUIRE MARTIN P. |
分类号 |
A61K31/47;A61K31/498;A61P9/00;A61P29/00;A61P35/00;A61P43/00;C07D215/20;C07D215/38;C07D241/44;C07D241/52;C07D241/54;C07D403/04;C07D405/12;(IPC1-7):A61K31/33;A61K31/495;C07D241/36;C07D401/00 |
主分类号 |
A61K31/47 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|